BRIEF-Protara Therapeutics Q2 EPS USD -0.35 Vs. IBES Estimate USD -0.41

Reuters
Aug 11
BRIEF-Protara <a href="https://laohu8.com/S/LENZ">Therapeutics</a> <a href="https://laohu8.com/S/QTWO">Q2</a> EPS USD -0.35 Vs. IBES Estimate USD -0.41

Aug 11 (Reuters) - Protara Therapeutics Q2 income from operations USD -16.586 million vs. IBES estimate USD -14.1 million.

  • Q2 operating expenses USD 16.586 million
  • Q2 net income USD -14.96 million vs. IBES estimate USD -13 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10